[HTML][HTML] Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein

Z Yao, L Zhang, Y Duan, X Tang, J Lu - Journal of Infection, 2024 - Elsevier
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has substantially damaged the global economy and human health. The …

Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates

M Prabhakaran, F Matassoli, D Leggat… - Science Translational …, 2024 - science.org
Durable humoral immunity is mediated by long-lived plasma cells (LLPCs) that reside in the
bone marrow. It remains unclear whether severe acute respiratory syndrome coronavirus 2 …

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants

L Chen, Y He, H Liu, Y Shang, G Guo - Frontiers in Immunology, 2024 - frontiersin.org
Coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic. The …

COV2Var, a function annotation database of SARS-CoV-2 genetic variation

Y Feng, J Yi, L Yang, Y Wang, J Wen… - Nucleic Acids …, 2024 - academic.oup.com
The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has resulted in the loss
of millions of lives and severe global economic consequences. Every time SARS-CoV-2 …

[HTML][HTML] Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain

Y Wang, Z Zhang, M Yang, X Xiong, Q Yan, L Cao… - Cell Reports, 2024 - cell.com
Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted
most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies

V Leducq, K Zafilaza, A Fauchois… - The Journal of …, 2024 - academic.oup.com
Background High-risk patients, often immunocompromised and not responding to vaccine,
continue to experience severe coronavirus disease 2019 (COVID-19) and death …

[HTML][HTML] Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted

DD Acar, W Witkowski, M Wejda, R Wei, T Desmet… - …, 2024 - thelancet.com
Summary Background SARS-CoV-2-neutralizing antibodies (nABs) showed great promise
in the early phases of the COVID-19 pandemic. The emergence of resistant strains …

Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome …

C Cianfarini, L Hassler, J Wysocki, A Hassan… - Cells, 2024 - mdpi.com
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) utilizes angiotensin-
converting enzyme 2 (ACE2) as its main receptor for cell entry. We bioengineered a soluble …

Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection

M Farjo, K Koelle, MA Martin, LL Gibson… - Journal of …, 2024 - Am Soc Microbiol
The global evolution of SARS-CoV-2 depends in part upon the evolutionary dynamics within
individual hosts with varying immune histories. To characterize the within-host evolution of …

Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater

MJ Conway, H Yang, LA Revord, MP Novay, RJ Lee… - BMC genomics, 2024 - Springer
Abstract Background Central Michigan University (CMU) participated in a state-wide SARS-
CoV-2 wastewater monitoring program since 2021. Wastewater samples were collected …